
About Thesis
Thesis is a Healthcare company based in New York (United States) founded in 2017 by Adam Greenfeld and Dan Freed. Personalized nootropics for brain health are provided via quizzes. It operates on a Direct-to-Consumer (D2C) and Subscription Services model. Thesis has raised $8.4 million across 1 funding round from investors including Unilever Ventures, REDO Ventures and ALIVE. Its website takethesis.com draws about 132 thousand monthly visits. Thesis offers products and services including Clarity, Motivation, Stress Reset, and Neuroprotection. Its focus areas include Supplements and Cognitive Health. Its competitors include Panaceutics, Wile and Gainful; 3 of its 3 listed competitors have raised funding.
Company details
Thesis is engaged in creating nootropic formulas aimed at enhancing cognitive functions such as focus, memory, and stress resilience. The company operates in the health and wellness sector, offering products designed to support brain health and performance. Solutions are developed through data-driven research and iterative testing to ensure effectiveness. Various formulations target specific needs like productivity, energy, balance, and long-term neuroprotection.
- Headquarters New York, United States
- Founders Adam Greenfeld, Dan Freed
- SectorsHealthcare
- Website category Health · Nutrition Diets and Fitness
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website takethesis.com
- Social LinkedIn Facebook Instagram
- Annual Revenue$1.35 M (USD)as on Dec 31, 2022
- Total Equity Funding$8.4M (USD)
in 1 rounds
- Latest Funding Round$8.4M (USD), Series A
May 2023
- InvestorsUnilever Ventures
& 3 more
Products & Services of Thesis
Thesis offers a comprehensive portfolio of products and services, including Clarity, Motivation, Stress Reset, and Neuroprotection.
Concentration and focus are enhanced by this supplement.
Brain energy and awareness are heightened by this product.
Mental calm and resilience are supported by this formula.
Memory and brain health are supported by this supplement.
Funding Insights of Thesis
Thesis has successfully raised a total of $8.4M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.4 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.4M
- Total Rounds 1
- Last Round Series A β $8.4M
- First Round $8.4M
(May 2023)
- Investors Count 4
All 1 funding rounds of Thesis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2023 | $8.4M | Series A | β | β |
4 investors in total: 4 institutional.
Investors in Thesis
Thesis has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Unilever Ventures, REDO Ventures and ALIVE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Corporate-backed venture capital firm focused on consumer tech and multiple sectors | unileverventures.com | London, United Kingdom | ||
Investments are directed by REDO Ventures toward software technology startups. | redoventures.com | New York, United States | ||
| alivevc.com | ||||
An early-stage venture fund is operated by Break Trail Ventures. | breaktrailventures.com | Columbus, USA |
Investor details for Thesis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Thesis
11 people are tracked at Thesis (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Adam Greenfeld | Co-Founder | Leadership |
Dan Freed | Co-Founder | Leadership |
Katy Marshall | Chief Business Officer | Leadership |
Amrita Kisnasamy | Associate Director Of CX | Leadership |
Matthew Rubin | Vice President Supply Chain | Leadership |
Jessica Skoczylas | Director of Brand Strategy | Leadership |
Mohit Bahel | Strategic Advisor | Team |
Gary Kliegman | Consultant & Advisor | Team |
Patricia Bogdan | Senior Manager, Brand Marketing | Team |
Will S. | Growth Analyst | Team |
Peter MacRobert | Advisor | Team |
Complete people profiles for Thesis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Thesis
2 dated milestones of Thesis across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Thesis is founded.
- Funding First funding round of $8.4M.
Competitors of Thesis
Thesis has 3 listed competitors in our database, 3 of them funded. They include Panaceutics, Wile and Gainful.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| panaceutics.com | 2013 | Danville, United States | $11.88M | An online platform for personalized nutrition and medication is provided. | ||
| wilewomen.com | 2021 | Portland, United States | $3M | Personalized supplements for women's wellness are offered via quizzes. | ||
| gainful.com | 2017 | San Francisco, United States | $8.62M | Personalized protein powders and hydration products are manufactured for subscribers. |
Detailed competitors of Thesis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Thesis
The website of Thesis (takethesis.com) receives about 132.5K visits a month and ranks #273,204 among all websites worldwide, #801 in Nutrition Diets and Fitness.
- Monthly visits132.5K
▲ 48.8% vs previous month
- Unique visitors48.4K
per month
- Global rank#273,204
among all websites
- Category rank#801
Health · Nutrition Diets and Fitness
- Bounce rate37%
- Pages per visit6.6
- Average visit1 min 58 sec
- DevicesDesktop 34% Β· Mobile 66%
Websites whose visitors overlap most with Thesis. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| onnit.com | 100% | 409.8K | #137,746 | View details | |
berkeleylife.com | berkeleylife.com | 97% | #1,366,305 | β | |
| doublewoodsupplements.com | 96% | #220,346 | View details | ||
naturalstacks.com | naturalstacks.com | 96% | #695,148 | β | |
1stphorm.com | 1stphorm.com | 96% | #90,854 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 39 similar websites and full traffic analytics for Thesis
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 39 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Thesis (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Thesis
Complete news archive for Thesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thesis
Thesis was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Thesis is headquartered in New York, United States. It is registered at New York, New York, United States.
Thesis is a funded company, having raised a total of $8.4M across 1 funding round to date. The company's 1st funding round was a Series A of $8.4M, raised on May 2023.
Annual revenue of Thesis is $1.35M as on Dec 31, 2022.
Thesis is engaged in creating nootropic formulas aimed at enhancing cognitive functions such as focus, memory, and stress resilience. The company operates in the health and wellness sector, offering products designed to support brain health and performance. Solutions are developed through data-driven research and iterative testing to ensure effectiveness. Various formulations target specific needs like productivity, energy, balance, and long-term neuroprotection.
Thesis's top competitors include Gainful, Panaceutics and Wile.
Thesis offers Clarity, Motivation, Stress Reset, and Neuroprotection.
Thesis has 4 investors. Key investors include Unilever Ventures, REDO Ventures, ALIVE, and Break Trail Ventures.
The website of Thesis receives about 132 thousand visits a month and ranks #273,204 among all websites worldwide.
